Ads
related to: Enbrel- Is RINVOQ Right For You?
RINVOQ® Could Be Right For You.
See RINVOQ® Clinical Trial Results.
- Watch Video
What Is RINVOQ®?
Watch A Video To Learn More.
- Treatment Didn't Help?
Looking To Change Treatments?
RINVOQ® Could Be The Right Fit.
- Register For More Info
Sign Up For More
Information About RINVOQ®.
- What Is RINVOQ®?
Learn About The FDA-Approved
Oral Pill.
- RINVOQ® Complete
Get Access To Prescription Savings
And Insurance Coverage Info.
- Is RINVOQ Right For You?
Search results
Is Pfizer Stock A Sell As Shares Hit An 11-Year Low Amid The Search For Its Next Big Break?
Investor's Business Daily· 2 days agoPrevnar sales inched 2% ahead to $6.44 billion. But other key products saw downfalls. Revenue from...
Needham & Company LLC Reiterates Buy Rating for Biogen (NASDAQ:BIIB)
ETF DAILY NEWS· 9 hours agoBiogen (NASDAQ:BIIB – Get Free Report)‘s stock had its “buy” rating reiterated by research analysts at Needham & Company LLC in a research note issued to investors on Wednesday, Benzinga reports ...
Brokerages Set Biogen Inc. (NASDAQ:BIIB) Price Target at $295.58
ETF DAILY NEWS· 10 hours agoShares of Biogen Inc. (NASDAQ:BIIB – Get Free Report) have earned a consensus rating of “Moderate Buy” from the twenty-seven research firms that are covering the company, Marketbeat reports.
Knights of Columbus Asset Advisors LLC Buys 2,800 Shares of Biogen Inc. (NASDAQ:BIIB)
ETF DAILY NEWS· 4 days agoKnights of Columbus Asset Advisors LLC raised its position in shares of Biogen Inc. (NASDAQ:BIIB – Free Report) by 97.9% during the fourth quarter, according to its most recent Form 13F filing ...
Sigma Planning Corp Has $1.85 Million Stock Holdings in Amgen Inc. (NASDAQ:AMGN)
ETF DAILY NEWS· 4 days agoSigma Planning Corp decreased its stake in Amgen Inc. (NASDAQ:AMGN – Free Report) by 65.9% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and ...
William Blair Comments on Biogen Inc.’s Q1 2024 Earnings (NASDAQ:BIIB)
ETF DAILY NEWS· 5 days agoBiogen Inc. (NASDAQ:BIIB – Free Report) – Investment analysts at William Blair cut their Q1 2024 earnings estimates for shares of Biogen in a report issued on Wednesday, April 17th. William ...
Biogen (BIIB) Scheduled to Post Quarterly Earnings on Wednesday
ETF DAILY NEWS· 4 days agoBiogen (NASDAQ:BIIB – Get Free Report) will be announcing its earnings results before the market opens on Wednesday, April 24th. Analysts expect the company to announce earnings of $3.48 per ...
Sumitomo Mitsui DS Asset Management Company Ltd Has $4.59 Million Stock Position in Biogen Inc....
ETF DAILY NEWS· 3 days agoSumitomo Mitsui DS Asset Management Company Ltd lessened its holdings in shares of Biogen Inc. (NASDAQ:BIIB – Free Report) by 0.4% during the 4th quarter, according to the company in its most ...
Ads
related to: Enbrel